CalciMedica, Accounts Payable from 2010 to 2024

CALC Stock   2.78  0.03  1.07%   
CalciMedica, Common's Accounts Payable is decreasing over the years with stable fluctuation. Overall, Accounts Payable is expected to go to about 1.9 M this year. Accounts Payable is the amount CalciMedica, Common Stock owes to suppliers or vendors for products or services received but not yet paid for. It represents CalciMedica, Common's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
1.4 M
Current Value
1.9 M
Quarterly Volatility
846.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CalciMedica, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CalciMedica, Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 55.1 K, Selling General Administrative of 14.6 M or Other Operating Expenses of 24.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.65. CalciMedica, financial statements analysis is a perfect complement when working with CalciMedica, Common Valuation or Volatility modules.
  
Check out the analysis of CalciMedica, Common Correlation against competitors.

Latest CalciMedica, Common's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of CalciMedica, Common Stock over the last few years. An accounting item on the balance sheet that represents CalciMedica, Common obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of CalciMedica, Common Stock are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. CalciMedica, Common's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CalciMedica, Common's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Pretty Stable
   Accounts Payable   
       Timeline  

CalciMedica, Accounts Payable Regression Statistics

Arithmetic Mean2,439,947
Geometric Mean2,256,139
Coefficient Of Variation34.69
Mean Deviation459,019
Median2,523,000
Standard Deviation846,510
Sample Variance716.6B
Range4.1M
R-Value(0.24)
Mean Square Error726.4B
R-Squared0.06
Significance0.38
Slope(45,856)
Total Sum of Squares10T

CalciMedica, Accounts Payable History

20241.9 M
20231.4 M
20222.9 M
2021527 K
20202.5 M
20194.6 M

About CalciMedica, Common Financial Statements

CalciMedica, Common stakeholders use historical fundamental indicators, such as CalciMedica, Common's Accounts Payable, to determine how well the company is positioned to perform in the future. Although CalciMedica, Common investors may analyze each financial statement separately, they are all interrelated. For example, changes in CalciMedica, Common's assets and liabilities are reflected in the revenues and expenses on CalciMedica, Common's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CalciMedica, Common Stock. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable1.4 M1.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:
Check out the analysis of CalciMedica, Common Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.11)
Return On Assets
(0.65)
Return On Equity
(0.84)
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.